CanSinoBIO (688185.SH) Stock Community - Hot Topic Discussions

Event Tracking

Nov7

CanSino Biologics Proposes to Use Surplus Reserve to Offset Accumulated Losses

08:40

Nov3

UBS Raises CanSino Biologics' 2026 Revenue Forecast and Cuts 2027 Forecast

06:26

Oct27

CanSinoBIO released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 692.57 M, actual EPS CNY 0.0966

01:00

CanSinoBIO released FY2025 Q3 earnings on October 27 After-Market (BJT), actual revenue CNY 310.24 M (forecast CNY 294.22 M), actual EPS CNY 0.1529

01:00

Oct25

CanSino Publishes an International Patent Application for a Recombinant Adenovirus Vaccine Formulation

00:00

Oct19

CanSinoBIO to release FY2025 Q3 earnings on October 27 After-Market BJT, forecast revenue CNY 294.22 M

00:30

Schedules

Filings

Oct27

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 310.24 M, Net Income 27.93 M, EPS 0.1529

Aug20

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 245.17 M, Net Income -1.94 M, EPS -0.0062

Apr29

Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 137.16 M, Net Income -11.55 M, EPS -0.05

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change